Key facts
- Agilent received expanded approval for its diagnostic test.
- The test is designed for patients considering Keytruda.
Agilent has announced that its diagnostic test has received expanded approval. This test is specifically designed for patients who are considering treatment with Keytruda. The expanded approval means the test can now be used for a wider range of potential Keytruda recipients, broadening its applicability in patient selection for this therapy.